These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 1560441

  • 1. Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).
    Leader H, Gordon RK, Baumgold J, Boyd VL, Newman AH, Smejkal RM, Chiang PK.
    J Med Chem; 1992 Apr 03; 35(7):1290-5. PubMed ID: 1560441
    [Abstract] [Full Text] [Related]

  • 2. Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
    Gordon RK, Breuer E, Padilla FN, Smejkal RM, Chiang PK.
    Mol Pharmacol; 1989 Nov 03; 36(5):766-72. PubMed ID: 2586491
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.
    Carroll FI, Abraham P, Parham K, Griffith RC, Ahmad A, Richard MM, Padilla FN, Witkin JM, Chiang PK.
    J Med Chem; 1987 May 03; 30(5):805-9. PubMed ID: 3494849
    [Abstract] [Full Text] [Related]

  • 8. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G, Waelbroeck M, Mash DC, Flynn DD.
    Mol Pharmacol; 1994 Dec 03; 46(6):1028-35. PubMed ID: 7808421
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
    Witkin JM, Gordon RK, Chiang PK.
    J Pharmacol Exp Ther; 1987 Sep 03; 242(3):796-803. PubMed ID: 3498817
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J, Marquez E, Laukkonen S, Martos F, Gómez A, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1991 Dec 03; 13(10):653-60. PubMed ID: 1770828
    [Abstract] [Full Text] [Related]

  • 14. Muscarinic receptor subtypes on rat pancreatic acini: secretion and binding studies.
    Louie DS, Owyang C.
    Am J Physiol; 1986 Aug 03; 251(2 Pt 1):G275-9. PubMed ID: 2426974
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. M3 muscarinic acetylcholine receptor coupling to PLC in rat exorbital lacrimal acinar cells.
    Mauduit P, Jammes H, Rossignol B.
    Am J Physiol; 1993 Jun 03; 264(6 Pt 1):C1550-60. PubMed ID: 8333505
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Deoxamuscaroneoxime derivatives as useful muscarinic agonists to explore the muscarinic subsite: demox, a modulator of orthosteric and allosteric sites at cardiac muscarinic M2 receptors.
    Angeli P, Marucci G, Buccioni M, Piergentili A, Giannella M, Quaglia W, Pigini M, Cantalamessa F, Nasuti C, Novi F, Maggio R, Qasem AR, Spampinato S.
    Life Sci; 2002 Feb 08; 70(12):1427-46. PubMed ID: 11883718
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.